Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?
- Octavio Luiz Motta Ferraz
- , Daniel Wei L. Wang
Research output: Contribution to journal › Article › peer-review
9
Citations
(Scopus)